Inactive Instrument

Press Releases Oramed Pharmaceuticals, Inc. Xetra

Equities

End-of-day quote Xetra Other stock markets
- ^EUR	-

05-15	Compugen Names David Silberman CFO	MT
05-09	Oramed Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Oramed Pharmaceuticals : Management Change/Compensation - Form 8-K	05-13	PU
Oramed: Q1 Earnings Snapshot	05-09	AQ
Oramed Pharmaceuticals : Update on the receipt of payments for the Scilex transaction	05-06	PU
Oramed Pharmaceuticals : 13D-Nadav Kidron	03-26	PU
Oramed Pharmaceuticals : Update on the receipt of payments for the Scilex transaction	03-19	PU
Oramed Pharmaceuticals : Other Report or Announcement	03-18	PU
Oramed Pharmaceuticals : Other Report or Announcement	03-18	PU
Oramed Pharmaceuticals : Other Report or Announcement	01-02	PU
Oramed Pharmaceuticals : Other Report or Announcement	12-24	PU
Oramed Pharmaceuticals : Form 8-K - Director Appointment- Dr. Daniel Aghion, effective as of January 1, 2024.	12-19	PU
Oramed: Q3 Earnings Snapshot	11-10	AQ
Oramed Pharmaceuticals : Other Report or Announcement	23-08-07	PU
Oramed Pharmaceuticals : Stalking Horse Stock Purchase Term Sheet - Form 8-K	23-08-07	PU
Oramed Signs Term Sheet with HTIT to Create a Joint Venture to Advance Oral Drug Delivery Technology Globally	23-08-02	PR
Oramed to Present at the 83rd American Diabetes Association Conference	23-06-21	AQ
Oramed to Present at Novel Therapies for Type 2 Diabetes & Obesity Summit	23-05-18	PR
Oramed: Q1 Earnings Snapshot	23-05-12	AQ
ORAMED PHARMACEUTICALS INC. : Change in Directors or Principal Officers (form 8-K)	23-05-01	AQ
Oramed Appoints Ben Shapiro to its Board of Directors	23-05-01	PR
ORAMED PHARMACEUTICALS INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)	23-03-06	AQ

No results for this search